Clinical Trial Update: An Extension Protocol for Subjects Who Successfully Completed PRO140_CD02 or PRO140_CD02_Open Label Study [Phase 2, Phase 3]

View source ↗

Summary

This clinical trial update describes an extension protocol for HIV subjects who completed the PRO140_CD02 studies. The study (Phase 2/3) is terminated, with res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Leronlimab (leronlimab)

Snippet

Sponsor: CytoDyn, Inc. | Conditions: Human Immunodeficiency Virus (HIV) | Phase 2, Phase 3 | Status: TERMINATED | Results posted: 2025-11-12